MAP - Market Access Podcast
Hosted by Dr Stefan Walzer and Stefan Walzer · Dr. Stefan Walzer
5.0from 7 ratings
- 121
- Episodes
- 57
- Transcribed
- 7
- Ratings
- Daily
- Cadence
- 2021
- First episode
About MAP - Market Access Podcast
Market Access (or alternatively reimbursement) in health care is THE key competence in order to be commercially successful with a new drug, medical device or digital health application. However, given the fact that market access is a complex field involving various disciplines and is an ever-changing field, it is difficult to be up to speed with the different evolvements across the world. MAP is THE bi-weekly Market Access Podcast provided by MArS Market Access & Pricing Strategy, which is your health care consultancy in the German-speaking markets and allows you to keep up to date with market access , reimbursement and pricing issues in the D-A-CH countries and around the world. With MAP you will get a summary of core market access systems and processes as well as latest changes in regulations including statements and opinions of core decision makers and stakeholders from various countries. The CEO and founder of MArS is also the driver behind MAP: Dr. Stefan Walzer works in the field of payer strategy, pricing, health economics and reimbursement since 2004 and is the founder and CEO of MArS Market Access & Pricing Strategy GmbH based in Germany. MArS makes it as easy as possible for you to get your Pharmaceutical, MedTech or digital health product to the market and of course get the price it deserves. Stefan previously worked as a payer consultant for various global pharmaceutical and medical device / diagnostic companies, successfully launching their products across the world. He was the Global Payer Strategy Leader for various products and compounds at F. Hoffmann – La Roche AG, where he successfully developed early payer strategies as well as launching and maintaining the reimbursement process for top brands and early compounds. Stefan is capable in translating the clinical and economic evidence into successful reimbursement submissions and pricing negotiations especially in Austria, Germany and Switzerland. Additionally he teaches market access, pricing and negotiations at the State University of Baden-Wuerttemberg and the University of Applied Sciences Weingarten-Ravensburg (both Germany). Besides other roles and responsibilities. Stefan was the head of the committee “Inpatient care” of the German Health Economic Association (DGGÖ). Furthermore he is also a member of the Austrian Health Economic Association (ATHEA) and the Swiss Health Economic Association (SGGÖ). Additionally, he is a member of the Access Advisory Committee of the Global Pneumonia Prevention Coalition. Stefan received a Master of Science in Economics from the University of Tuebingen (Germany), a PhD in Health Economics from the University of Zurich (Switzerland) and a post-graduate diploma in Clinical Trials from the London School of Hygiene and Tropical Medicine (UK). He is co-author of more than 40 peer-reviewed scientific articles and more than 300 scientific abstracts.
- Publisher
- Dr. Stefan Walzer
- Category
- business · health & fitness · science
- Language
- en
- Explicit
- No
- First episode
- 2 Sept 2021
- Latest episode
- 1 Oct 2026
Latest episodes
57 of 121 episodes have a transcript.
1 Oct 2026TRANSCRIPT
What Will It Take to Keep Biotech Growing in Europe, Rainer Westermann?
15 Sept 2026TRANSCRIPT
How Do You Build a High-Performing Team in Pharma, Dr. Maurice Kleber?
1 Sept 2026TRANSCRIPT
Where Does AI Really Add Value in Market Access, Dr. Seye Abogunrin?
Inside a recent episode
What Will It Take to Keep Biotech Growing in Europe, Rainer Westermann?
Published 1 Oct 2026 · Transcript excerpt
[…] I think at the beginning I said we do have a lot of capital in Europe. It's just not productive capital. And we also need to change our viewpoint. We talked a little bit about it, and I really hate the word risk. Yes, there is risk, but in the end, it's nothing ventured, nothing gained. Venture capital is different from risk capital. Yes, it is inherently more risky, but it is also something that can bring tremendous rewards. And also, we shouldn't forget, venture capital is the only asset class that consistently invests in innovation. With all the risk that comes with it, but strangely enough, limited partners come back and they put more money into these funds. […]
Read the full transcript with a Pod Engine plan.
See plansWho has been a guest on MAP - Market Access Podcast
Names identified in recent episode analyses. Showing up to five guests.
- Rainer Westermann
- Dr Maurice Kleber
- Dr Seye Abogunrin
- Dr Björn Schwander
- Julie Frappier
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
- Apple Podcasts (US)
- 5.0 / 5
- 1 ratings
- Spotify
- 5.0 / 5
- 6 ratings
Podcast Authority Score: 45 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
- Quality
- 57
- Social presence
- 0
- YouTube
- 0
- Engagement
- 81
Contact MAP - Market Access Podcast
- Guest appearances
- Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Shows with a similar audience
Questions about MAP - Market Access Podcast
Who hosts MAP - Market Access Podcast?
Dr Stefan Walzer and Stefan Walzer host the show. Published by Dr. Stefan Walzer.
How often do new episodes come out?
The show publishes daily, based on its RSS feed.
Does MAP - Market Access Podcast take guests?
Yes. Guests have been identified in episode analyses.
Where can I read transcripts?
57 of 121 episodes have a transcript on Pod Engine. Full transcripts are available with a Pod Engine plan.
Host of MAP - Market Access Podcast?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show
Podcast research with Pod Engine